Examkin

Soru

Zorluk: OrtaEnd-of-Life and Palliative Care

Match the following clinical scenarios of terminally ill patients receiving end-of-life care with the most appropriate pharmacologic intervention for their symptoms.

  • An 82-year-old actively dying man develops noisy, gurgling respirations due to the pooling of oropharyngeal secretions.Sublingual glycopyrrolate
  • A 68-year-old woman with metastatic breast cancer experiences severe, distressing dyspnea at rest despite adequate oxygen saturation.Low-dose oral morphine
  • A 74-year-old man with end-stage pancreatic cancer develops terminal delirium with severe agitation that is completely refractory to haloperidol.Continuous intravenous midazolam
  • A 61-year-old woman with advanced ovarian cancer develops severe nausea and vomiting attributed to opioid-induced delayed gastric emptying.Oral metoclopramide

Cevap

The correct pairings match each specific end-of-life symptom with its first-line evidence-based pharmacologic intervention: pooling secretions (death rattle) with glycopyrrolate, refractory dyspnea with morphine, refractory terminal delirium with midazolam, and opioid-induced gastroparesis with metoclopramide.
Each pairing correctly addresses the pathophysiology and standard palliative care guidelines for end-of-life symptoms: anticholinergics (glycopyrrolate) for secretions, opioids (morphine) for dyspnea, benzodiazepines (midazolam) for refractory delirium, and prokinetics (metoclopramide) for gastroparesis.

Adım Adım Çözüm

1
Analyze the underlying cause of the noisy breathing in the 82-year-old patient.
Identified as pooled oropharyngeal secretions due to loss of the swallowing reflex.
Determines the need for an anticholinergic drying agent rather than deep suctioning, which can be distressing.
2
Evaluate the management of refractory dyspnea without hypoxia in the 68-year-old patient.
Identified low-dose opioids as the gold standard treatment.
Supplemental oxygen is ineffective for non-hypoxic dyspnea; opioids directly relieve the subjective sensation of breathlessness.
3
Determine the next step for terminal delirium refractory to typical antipsychotics in the 74-year-old patient.
Identified palliative sedation with midazolam as appropriate.
When standard therapies fail in an actively dying patient with a prognosis of days to hours, palliative sedation is ethically and clinically indicated to relieve suffering.
4
Identify the mechanism of nausea in the 61-year-old patient on opioids.
Recognized opioid-induced gastroparesis.
Directs therapy to a dopamine antagonist with prokinetic properties like metoclopramide, which specifically targets gastric stasis.

Anahtar Kavram

Pharmacologic management of severe symptoms in end-of-life and palliative care.
Bu soruyu puanla

Konular

End-of-Life and Palliative Care

Bu konudan daha fazla soru